We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use a cost benefit analysis to evaluate your digital health product.
AMRHAI (antimicrobial resistance and healthcare associated infections) is the national reference unit for investigating AMR in healthcare-associated bacteria.
How to use an interrupted time series to evaluate your digital health product.
Community diagnostic centre (CDC) sites have already delivered over 7 million tests, checks and scans to patients across England.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Information for patients, public and health care professionals.
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart, to evaluate blood flow and aid in the diagnosis or assessment of...
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Guidance for those conducting research and development on genetic resources.
Information on Bartonella and how to obtain diagnostic and reference services.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
How to use a budget impact analysis to evaluate your digital health product.
NHS patients benefit from 6 million more checks at centres across England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).